CAPITOL HEALTH LIMITED (CAJ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CAJ - CAPITOL HEALTH LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.38

21 Sep
2021

0.000

OPEN

$0.38

0.000

HIGH

$0.40

621,450

LOW

$0.37

TARGET
$0.43 13.2% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . GXL . HSO . MPL . MVF . NHF . HLS . RHC . SHL . VRT . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
CAJ: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx 1.2 1.4 xxx
DPS (cps) xxx 1.0 1.2 xxx
EPS Growth xxx 100.0% 17.9% xxx
DPS Growth xxx 0.0% 21.0% xxx
PE Ratio xxx N/A 28.3 xxx
Dividend Yield xxx N/A 3.1% xxx
Div Pay Ratio(%) xxx 85.5% 87.7% xxx

Dividend yield today if purchased 3 years ago: 3.45%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.56

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 04/03 - 0.5c (100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx1.2
DPS All xxxxxxxxxxxxxxx1.0
Sales/Revenue xxxxxxxxxxxxxxx178.0 M
Book Value Per Share xxxxxxxxxxxxxxx14.2
Net Operating Cash Flow xxxxxxxxxxxxxxx40.9 M
Net Profit Margin xxxxxxxxxxxxxxx6.70 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Assets xxxxxxxxxxxxxxx4.40 %
Return on Equity xxxxxxxxxxxxxxx8.23 %
Return on Total Capital xxxxxxxxxxxxxxx8.64 %
Capex xxxxxxxxxxxxxxx7.6 M
Capex % of Sales xxxxxxxxxxxxxxx4.29 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx19.1 M

Return on Assets

Return on Equity

Return on Total Capital

Capex

Capex % of Sales

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Credit Suisse

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

27/08/2021

2

Accumulate

$0.43

13.16%

FY21 results revealed continued execution of the three-year strategic plan. Ord Minnett found the results commendable in the context of the five lockdowns that affected Victoria, which is the dominant geography for the company's portfolio.

The broker notes work to be done in FY22 includes three greenfield/brownfield opportunities. The balance sheet is strong and there is $110m in available debt facilities.

Negligible gearing signals to the broker M&A will be hard to ignore. Ord Minnett transfers coverage to another analyst. Accumulate rating maintained. Target rises to $0.43 from $0.36.

FORECAST
Ord Minnett forecasts a full year FY22 dividend of 1.00 cents and EPS of 1.10 cents.
Ord Minnett forecasts a full year FY23 dividend of 1.10 cents and EPS of 1.40 cents.

CAJ STOCK CHART